25.06.2010
РОССИЙСКАЯ АКАДЕМИЯ НАУК

УРАЛЬСКОЕ ОТДЕЛЕНИЕ

ИНСТИТУТ ХИМИИ TBEPДОГО ТЕЛА
   
| | | | |
| | | | | |
 25.06.2010   Карта сайта     Language По-русски По-английски
Новые материалы
Экология
Электротехника и обработка материалов
Медицина
Статистика публикаций


25.06.2010


US chemical society loses legal battle with software firm



24 June 2010



The American Chemical Society (ACS) is reeling after being stymied for a second time in its attempt to sue the Columbus, Ohio-based research software provider Leadscope for stealing its intellectual property. Now ACS will likely have to pay Leadscope and its three founding scientists nearly $40 million.



ACS handing over cash








The ACS is facing the prospect of handing over millions of dollars to Leadscope



The lawsuit, which has been going on for eight years, came to an end on 15 June when an Ohio appellate court upheld the $34.4 million (£23 million) award for Leadscope in its countersuit, including $7.5 million in punitive damages and $7.9 million in legal fees and expenses.


Leadscope's three founders are former ACS employees, and the association sued the company in 2002 claiming that it was created with stolen trade secrets from ACS that enabled it to patent a software programme for drug companies that helps shorten the drug development process. 


When the case was tried in a lower court in 2008, jurors found no evidence of trade secret misappropriation, and Leadscope and its founders were awarded damages on their counterclaims for defamation, unfair competition and intentionally damaging its business. ACS says it 'respectfully disagrees' with the higher court's 15 June decision to uphold that earlier judgment. The association claims that it has 'substantial evidence' to support its case against Leadscope.  


When contacted by Chemistry World, ACS would not go beyond a statement issued following the court ruling, in which it says it is still assessing the details of the court's findings and will determine whether or not to elevate the matter to the Ohio Supreme Court. But the association does not anticipate that paying the $40 million in fines would result in changes to staff, ongoing programmes, or membership dues.


For its part, Leadscope is celebrating the latest development. 'This is just another step toward the end of this really protracted legal entanglement,' the company's president and chief executive, Loftus Lucas, tells Chemistry World. 'It should have been the end a long time ago.'


It is extremely bad for business when a company's intellectual property is challenged, Lucas states. 'Our primary clients are pharmaceutical companies, and it is very difficult to convince a company to place a huge bet on drug development using software when the biggest chemical society in the world is challenging your ownership of that software,' he tells Chemistry World. 


Rebecca Trager, US correspondent for Research Europe



Дизайн и программирование N-Studio 
А Б В Г Д Е Ё Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я © 2004-2024 ИХТТ УрО РАН
беременность, мода, красота, здоровье, диеты, женский журнал, здоровье детей, здоровье ребенка, красота и здоровье, жизнь и здоровье, секреты красоты, воспитание ребенка рождение ребенка,пол ребенка,воспитание ребенка,ребенок дошкольного возраста, дети дошкольного возраста,грудной ребенок,обучение ребенка,родить ребенка,загадки для детей,здоровье ребенка,зачатие ребенка,второй ребенок,определение пола ребенка,будущий ребенок медицина, клиники и больницы, болезни, врач, лечение, доктор, наркология, спид, вич, алкоголизм православные знакомства, православный сайт творчeства, православные рассказы, плохие мысли, православные психологи рождение ребенка,пол ребенка,воспитание ребенка,ребенок дошкольного возраста, дети дошкольного возраста,грудной ребенок,обучение ребенка,родить ребенка,загадки для детей,здоровье ребенка,зачатие ребенка,второй ребенок,определение пола ребенка,будущий ребенок